Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma

Emanuele Zucca, Luca Ceriani, Andrew S. Davies, Giovannino Ciccone, Umberto Ricardi, Alice Di Rocco, Iryna Kryachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Vittorio Ruggero Zilioli, Sara Usai, Luca Arcaini, Elsa Pennese, Anna Dabrowska-Iwanicka, Andrés José María Ferreri, Franceso Merli, Wei Li Zhao, David Hodgson, Codruta Ionescu, Luigi Rigacci, Claudia Cellini, Caterina Stelitano, Stefano Volpetti, Carla Minoia, Michele Spina, Alexander Fossa, George Mikhaeel, Kate Cwynarski, Andrea Janikova, Yana Stepanishyna, Mats Jerkeman, Andreas Huettmann, Maria Gomes da Silva, Don A. Stevens, Sally F Barrington, Bogdan Małkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Oreste Bagni, Kelly Cozens, Sonia Perticone, Nicoletta Ielmini, Letizia Deantonio, Jan Walewski, Marek Trneny, Mary Gospodarowicz, Franco Cavalli, Peter Johnson, Maurizio Martelli

Blood (2023) 142 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2023-174093

Published: 2023

Journal Articles

Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation

Blood (2022) 140 (Supplement 1): 3532–3533.

https://doi.org/10.1182/blood-2022-156571

Published: 2022

Journal Articles

The Impact of Age on the Outcome of Primary Treatment for Classical Hodgkin's Lymphoma: 70 Years of Age Is a Clinical Relevant Cutpoint and the Most Important Predictor of Overall Survival

Lourdes Calvente, MD, Manjula Maganti, MSc, Mary Gospodarowicz, MD FRCPC, David C. Hodgson, MD MPH, FRCPC, Danielle Rodin, MD MPH, FRCPC, Alexander Sun, MD FRCPC, Richard Tsang, MD FRCPC, Robert Kridel, MDMPH,PhD, Vishal Kukreti, MD, Anca Prica, MD, Michael Crump, MD FRCPC, John Kuruvilla, MD

Blood (2019) 134 (Supplement_1): 1559.

https://doi.org/10.1182/blood-2019-130282

Published: 2019

Journal Articles

Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) Vs. Classical Hodgkin Lymphoma (cHL) at Princess Margaret Cancer Centre

Jeffery Ames, MD, Manjula Maganti, MSc, Bethany E Monteith, MD, David C. Hodgson, MD, Vishal Kukreti, MD, John G. Kuruvilla, MD, Anca Prica, MD, Richard Tsang, MD, Alex Sun, MD, Mary Gospodarowicz, MD, Melania Pintilie, MSc, Michael Crump, MD

Blood (2015) 126 (23): 3863.

https://doi.org/10.1182/blood.V126.23.3863.3863

Published: 2015

Journal Articles

Clinical Characteristics and Treatment Outcomes in Patients Diagnosed with Primary Mediastinal Large B-Cell Lymphoma at Princess Margaret Cancer Centre from 1994-2012

Anna M. Dyszkiewicz-Korpanty, MD PhD, Manjula Maganti, David C. Hodgson, MD, John G. Kuruvilla, MD, Vishal Kukreti, MD, Rodger E. Tiedemann, MD PhD, Alexander Sun, MD, Richard Tsang, MD, Mary Gospodarowicz, MD, Melania Pintilie, Anna Porwit, MDPhD, Michael Crump, MD

Blood (2014) 124 (21): 4447.

https://doi.org/10.1182/blood.V124.21.4447.4447

Published: 2014

Journal Articles

Follicular Lymphoma In Young Adults: Clinical Characteristics and Early Treatment Outcomes

Shane A Gangatharan, MBBS, FRACP, FRCPA, John Kuruvilla, MD, Vishal Kukreti, MD, FRCPC, Rodger E. Tiedemann, MBChB, PhD, FRACP, FRCPA, Mary Gospodarowicz, MD, David C. Hodgson, MD, Alex Sun, MD, Richard Tsang, MD, Manjula Maganti, Melania Pintilie, Michael Crump, MD FRCPC

Blood (2013) 122 (21): 4273.

https://doi.org/10.1182/blood.V122.21.4273.4273

Published: 2013

Journal Articles

Treatment of Stage I-II A Non-Bulky Hodgkin's Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone

Blood (2012) 120 (21): 548.

https://doi.org/10.1182/blood.V120.21.548.548

Published: 2012

Journal Articles

Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy That Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6

Ralph M. Meyer, MD, Mary Gospodarowicz, MD, Joseph M. Connors, MD, Robert G Pearcey, MD, Woodrow A Wells, MD, Jane N. Winter, MD, Sandra J. Horning, MD, A. Rashid Dar, MD, Chaim Shustik, MD, Douglas A. Stewart, MD, Michael Crump, MD, FRCPC, Marina S Djurfeldt, MSc, Bingshu E Chen, PhD, Lois E Shepherd, M.D.

Blood (2011) 118 (21): 590.

https://doi.org/10.1182/blood.V118.21.590.590

Published: 2011

Journal Articles

A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)

Leo I Gordon, MD, FACP, Fanxing Hong, PhD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Henry Wagner, MD, Patrick J Stiff, MD, Bruce D. Cheson, MD, Mary Gospodarowicz, MD, FRCPC, Ranjana Advani, MD, Brad Kahl, MD, Jonathan W. Friedberg, MD, Kristie A. Blum, MD, Thomas M. Habermann, MD, Joseph Tuscano, Richard Hoppe, MD, Sandra J. Horning, MD

Blood (2010) 116 (21): 415.

https://doi.org/10.1182/blood.V116.21.415.415

Published: 2010

Journal Articles

Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors

Deirdre A. Hill, Ethel Gilbert, Graça M. Dores, Mary Gospodarowicz, Flora E. van Leeuwen, Eric Holowaty, Bengt Glimelius, Michael Andersson, Tom Wiklund, Charles F. Lynch, Mars van't Veer, Hans Storm, Eero Pukkala, Marilyn Stovall, Rochelle E. Curtis, James M. Allan, John D. Boice, Lois B. Travis

Blood (2005) 106 (10): 3358–3365.

https://doi.org/10.1182/blood-2005-04-1535

Published: 2005

Journal Articles

Extranodal Follicular Lymphoma - a Retrospective Review and Comparison with Localized Nodal Follicular Lymphoma.

Vishal Kukreti, MD, FRCPC, MSc, Peter Petersen, MD, PHD, Melania Pintilie, Richard Tsang, MD, FRCPC, Michael Crump, MD, FRCPC, Mary Gospodarowicz, MD, FRCPC, FRCR(HON)

Blood (2004) 104 (11): 1375.

https://doi.org/10.1182/blood.V104.11.1375.1375

Published: 2004

NARROW

Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma

Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation

The Impact of Age on the Outcome of Primary Treatment for Classical Hodgkin's Lymphoma: 70 Years of Age Is a Clinical Relevant Cutpoint and the Most Important Predictor of Overall Survival

Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) Vs. Classical Hodgkin Lymphoma (cHL) at Princess Margaret Cancer Centre

Clinical Characteristics and Treatment Outcomes in Patients Diagnosed with Primary Mediastinal Large B-Cell Lymphoma at Princess Margaret Cancer Centre from 1994-2012

Follicular Lymphoma In Young Adults: Clinical Characteristics and Early Treatment Outcomes

Treatment of Stage I-II A Non-Bulky Hodgkin's Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone

Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy That Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6

A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)

Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors

Extranodal Follicular Lymphoma - a Retrospective Review and Comparison with Localized Nodal Follicular Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only